

Results-driven Regulatory Affairs leader with 20 years of experience in the pharmaceutical industry, specializing in drug substances CMC (DMFs, NDAs, ANDAs) from development to global filings. Adept at strategic regulatory planning, team leadership, and cross-functional collaboration, with expertise in handling complex molecules and ensuring timely regulatory submissions across global markets.